Join
Live feed
·
INSIDERFilingvia Quantisnow
Ovid Therapeutics Inc. logo

New insider Papadopoulos Stelios claimed ownership of 200,000 shares (SEC Form 3)

ByQuantisnow·Wall Street's wire, on your screen.
OVID· Ovid Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OVID (Ovid Therapeutics Inc.) and more on Quantisnow.

New insider Papadopoulos Stelios claimed ownership of 200,000 shares (SEC Form 3) | Quantisnow